Pathophysiology and Therapy of Neuropathic Pain

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: 28 June 2024 | Viewed by 618

Special Issue Editors


E-Mail Website
Guest Editor
Clinical Fellow, Head Fellow of Research, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
Interests: neuropathic pain; neuralgia; mechanical ventilation; ARDS; respiratory failure; perioperative medicine; sugammadex; delirium; COVID-19; quantum medicine; biophysics; dexmedetomidine; dexamethasone; ketamine

E-Mail Website
Guest Editor
Director of CARE, Associate Professor, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA
Interests: lung protective ventilation; neuropathy; muscle relaxants; mechanical ventilation; ARDS; respiratory failure; perioperative medicine; sugammadex; delirium, electrical impedance tomography; xenon; dexmedetomidine; dexamethasone; ketamine

Special Issue Information

Dear Colleagues,

Neuropathic pain arises from damage or disease affecting the somatosensory nervous system. It is a common and debilitating symptom that significantly reduces quality of life, and is often inadequately treated. The pain presents in different forms, including persistent or intermittent sensations of burning, pricking, or squeezing, and can be evoked by a light touch or being cold. The mechanisms underlying neuropathic pain are diverse, involving ectopic nerve activity, compressed nerves or roots, dorsal root ganglia and thalamus, signals spreading to adjacent areas, and peripheral and central sensitization. Sensitization may be caused by structural changes, cell–cell interactions, and molecular signaling alterations, such as ion channel modifications, immune cell activation, glial-mediated processes, and epigenetic regulation.

Various conditions contribute to the onset of neuropathic pain, including metabolic disorders, viral infections, autoimmune disorders, chemotherapy-induced neuropathies, trauma, inflammatory disorders, hereditary neuropathies, and channelopathies. Efforts have been made to enhance therapeutic options for neuropathic pain, utilizing gabapentinoids, tricyclic antidepressants, selective serotonin–norepinephrine reuptake inhibitors, lidocaine, capsaicin, tramadol, and botulinum toxin.

Despite advances in understanding these mechanisms and therapies, neuropathic pain remains challenging to comprehend and treat, representing an unmet medical need. The pathophysiology is highly diverse, with numerous molecular mechanisms being involved. Although scientific knowledge is expanding, treatment options have not seen significantly improved, indicating a gap in our understanding of neuropathic pain. Exciting fields of research are emerging, unraveling underlying neural circuits and providing critical insights into new pharmacological and biophysical strategies. Overcoming obstacles in developing targeted therapies and addressing translation challenges between animal and human studies remain goals to be achieved.

We cordially invite you and your colleagues to contribute original research articles and reviews focusing on neuropathic pain's clinical presentation, physiological mechanisms, treatment, prognosis, and prevention. By comprehending the links between neurochemical, inflammatory, and structural mechanisms and specific clinical presentations of neuropathic pain, we can improve rational pain management and significantly advance our understanding of this critical phenomenon.

Dr. Aiman Suleiman
Dr. Maximilian Sebastian Schaefer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neuron
  • neuropathic pain
  • neuralgia
  • nerve damage
  • neuropathy
  • neural circuit
  • nervous system
  • sensitization
  • channelopathy
  • pain

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 789 KiB  
Review
Botulinum Toxin in Chronic Lateral Epicondylitis, from Tendon to Muscle Approach—A Review
by Daniela Poenaru, Miruna Ioana Sandulescu, Claudia-Gabriela Potcovaru and Delia Cinteza
Life 2024, 14(4), 528; https://doi.org/10.3390/life14040528 - 20 Apr 2024
Viewed by 343
Abstract
Background: Chronic lateral epicondylitis challenges the therapeutical approach; underlying mechanisms are incompletely understood; neuropathic pain and central and peripheral sensitization may explain the fact that botulinum toxin has been found to play a role in pain and function management. Methods: We searched the [...] Read more.
Background: Chronic lateral epicondylitis challenges the therapeutical approach; underlying mechanisms are incompletely understood; neuropathic pain and central and peripheral sensitization may explain the fact that botulinum toxin has been found to play a role in pain and function management. Methods: We searched the literature for MeSH terms: lateral epicondylitis or synonyms and botulinum toxin. Results: We found 14 papers containing trials on botulinum toxin injection into the tendon or into the extensor muscles (specifically, extensor carpi radialis brevis and extensor communis digitorum). We followed the administration pathways, doses, timing, and side effects. Conclusions: With a chronic course, the focus of the therapy shifts from the afflicted tendon to the inserting muscles, as muscle contracture may create a vicious loop to perpetuate and aggravate the disease. Doses, timing, and side effects are discussed. Full article
(This article belongs to the Special Issue Pathophysiology and Therapy of Neuropathic Pain)
Show Figures

Figure 1

Back to TopTop